Data as of Mar 14
| -0.68 / -2.85%|
The 8 analysts offering 12-month price forecasts for Celldex Therapeutics Inc have a median target of 36.50, with a high estimate of 45.00 and a low estimate of 31.00. The median estimate represents a +57.74% increase from the last price of 23.14.
The current consensus among 8 polled investment analysts is to Buy stock in Celldex Therapeutics Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.